Intra-Cellular Therapies acquisition will expand J&J’s presence in neurology space, says GlobalData Read more
Alembic Pharma gets USFDA final approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Read more